Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
22nd Century Group (NASDAQ: XXII) pioneers plant-based solutions for tobacco harm reduction through advanced biotechnology. This news hub provides investors and stakeholders with essential updates on regulatory milestones, product innovations, and operational developments central to the company's mission of reducing nicotine addiction.
Access authoritative coverage of FDA communications, VLN product advancements, and manufacturing capacity updates. Our curated collection includes earnings reports, patent filings, and scientific research collaborations that demonstrate 22nd Century's leadership in developing reduced-nicotine tobacco products.
Key updates feature the company's Modified Risk Tobacco Product authorization, progress in international market expansion, and innovations in nicotine biosynthesis control. Regular updates ensure informed tracking of this biotechnology firm's unique position at the intersection of public health and commercial tobacco production.
Bookmark this page for streamlined access to verified corporate announcements and analysis-free reporting on 22nd Century's progress in redefining tobacco consumption through science-driven solutions.
22nd Century Group (NASDAQ: XXII), a tobacco products company focused on nicotine control solutions, has announced that CEO Larry Firestone will deliver a corporate update presentation at the Emerging Growth Conference on May 21, 2025, at 12:00 PM ET. The presentation will cover recent company developments and include a potential Q&A session.
Investors can submit questions in advance via email and register for the event through the provided webcast link. For those unable to attend live, an archived recording will be available on EmergingGrowth.com and the Emerging Growth YouTube Channel.
22nd Century Group (NASDAQ: XXII) has completed the sale of its Needle Rock Farms assets for net proceeds of approximately $770,000 after expenses. The assets were previously related to the company's hemp cannabis business, which was divested in December 2023. CEO Larry Firestone stated that the proceeds will strengthen the company's cash position and support their 2025 revenue growth strategies, including new VLN® and Partner VLN® launches. The company will report its Q1 2025 results on May 13, 2025.
22nd Century Group (NASDAQ: XXII) has announced an additional $1.0 million debt reduction to its senior lender, bringing its total debt principal to approximately $3.9 million. Year to date, the company has achieved a total debt reduction of about $3.8 million. CEO Larry Firestone highlighted that total debt obligations have decreased significantly from approximately $20 million in December 2023 when he joined the company. The tobacco products company aims to become debt-free to focus resources on growth opportunities in contract manufacturing, reduced nicotine content, and branded products. The company will report its Q1 2025 results on May 13, 2025.
22nd Century Group (NASDAQ: XXII), a tobacco products company focused on nicotine control solutions, has scheduled its Q1 2025 earnings announcement for May 13, 2025. The company will release its financial results via press release at 6:00 AM ET, followed by a webcast at 8:00 AM ET.
CEO Larry Firestone and CFO Dan Otto will lead the webcast, covering financial performance, recent developments, and outlining plans for 2025. Investors can access the webcast through the company's IR website at ir.xxiicentury.com/events, with registration recommended 10 minutes before start time.
22nd Century Group (XXII) announced a proposed settlement of stockholder derivative actions pending in New York and Nevada courts. The settlement, dated March 4, 2025, addresses allegations that company directors and officers breached their fiduciary duties through a paid stock promotion scheme and issued misleading statements.
The settlement requires the company to implement corporate governance reforms and procedures. 22nd Century will pay $768,333 in attorneys' fees and expenses, with additional service awards of up to $2,500 for each of the four plaintiffs to be paid from the fee amount.
A Settlement Hearing is scheduled for July 16, 2025, where the court will determine the fairness and adequacy of the settlement. Current stockholders have until June 25, 2025 to file objections. Upon final approval, the plaintiffs will dismiss their complaints with prejudice.
22nd Century Group (XXII) has secured two new agreements with former customers for filtered cigar production, expanding its Contract Manufacturing Operations (CMO). The company expects to initiate shipments in Q2 2025, with projected annual volumes of 500,000+ cartons.
This development follows a previous agreement signed in Q3 2024 with another filtered cigar customer. The new agreements are structured to provide appropriate gross margins and consistent volume, strengthening the company's CMO platform and supporting its growth strategy. Additionally, these partnerships could potentially facilitate the expansion of VLN® through established retail channels and trusted partner brands.
22nd Century Group (NASDAQ: XXII) CEO Larry Firestone issued a corporate update highlighting the company's strategic transformation and growth plans. The company has streamlined operations by focusing solely on tobacco, reducing cash burn, and cutting ~$18M in debt. Their flagship product VLN®, the only FDA-authorized cigarette with 95% less nicotine, is positioned to address a significant market opportunity where nearly 29 million adult smokers seek alternatives.
The company's contract manufacturing (CMO) business serves as their operational backbone, providing manufacturing and supply chain services to secondary tobacco brands. Starting Q2 2025, they plan to launch rebranded VLN® products (Gold, Red, and Green Menthol) across 5,000+ stores, targeting expansion into the 272,000 stores nationwide. The company is also partnering with CMO customers to launch partner-branded VLN® products, aiming to establish the Very Low Nicotine Content (VLNC) category in the $85 billion tobacco industry.
22nd Century Group (XXII) reported Q4 and full-year 2024 financial results, showing declining performance with net revenues decreasing to $4.0 million from $5.9 million in Q3 2024. The company posted a gross loss of $(1.3) million and increased net loss to $4.2 million.
Key developments include launching new VLN® branding for Q2 2025 shipment and announcing partnership with Smoker Friendly. The company signed a five-year expanded license and manufacturing agreement covering 11 existing products and eight new premium products.
Q4 2024 breakdown shows cigarette revenues at $3.3 million (228,000 cartons), filtered cigars at $0.8 million, and negligible cigarillo distribution revenue. VLN® cigarette revenue was $(0.1) million due to rebates and marketing incentives.
The company ended fiscal 2024 with $3.3 million in net debt and is implementing a new growth strategy for 2025, focusing on profitable contract manufacturing and relaunching reduced nicotine VLN® cigarette business through both branded and private label partner products.
22nd Century Group (Nasdaq: XXII) has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 20, 2025. The company will release its earnings report via press release at 6:00 AM ET, followed by a webcast at 8:00 AM ET.
During the webcast, Chairman and CEO Larry Firestone and CFO Dan Otto will present the financial results, discuss recent developments, and outline plans for 2025. The event will be accessible through the company's Investor Relations website, with both live and archived versions available.
FAQ
What is the current stock price of 22Nd Century (XXII)?
What is the market cap of 22Nd Century (XXII)?
